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In the present study we examined whether two virgin olive oils (VOO1 and VOO2), of the same
variety (Olea europaea var. hojiblanca) and with a similar composition of minor components
but differing in the content of triacylglycerol molecular species, had different effects on blood
pressure and plasma lipid levels in a healthy elderly population. Thirty-one participants, aged
84·9 (SD 6·4) years, were asked to participate in the study. No differences were found with
regard to blood pressure after both experimental periods (VOO1 and VOO2). However,
plasma total cholesterol and LDL-cholesterol were reduced only after VOO1 (P,0·01). The
reduction of plasma cholesterol concentrations was related to the incorporation of oleic acid
into plasma cholesteryl esters and phospholipids, which was higher after VOO1 (P,0·01).
Indeed, the oleic acid concentration in cholesteryl esters and phospholipids strongly correlated
with plasma total cholesterol and LDL-cholesterol levels in all experimental periods studied
(r 2.0·418, P,0·07), except for phospholipids in VOO1 (P=0·130 for total cholesterol and
P=0·360 for LDL-cholesterol). These results have demonstrated that blood pressure and
plasma lipids can be modified by the consumption of VOO in elderly people, but that the
extent of such modification depends on the composition and amount of active minor com-
ponents and triacylglycerol molecular species.
Virgin olive oil: Blood pressure: Cholesterol: Fatty acids: Elderly
In recent decades, ageing has acquired great interest, not
only because elderly people form an increasing percentage
of the population, but also because they can now enjoy an
active and productive life beyond the retirement age. In
elderly people, plasma cholesterol levels decline after age
70 years, leading to a reduction of the total choles-
terol:HDL-cholesterol ratio (Newschaffer et al. 1992;
Lamon-Fava et al. 1994; Wilson et al. 1994). However,
in this population, a concomitant decrease of the
absolute risk of CHD is not observed (Benfante et al.
1992; Krumholz et al. 1994). Both isolated systolic hyper-
tension and combined systolic–diastolic hypertension are
considered as major risk factors for cardiovascular disease
in the elderly (Moser, 1999; Forette, 1999; Forette et al.
2000); for the moment, results on the effect of diet on
blood pressure in very old subjects (.85 years) are
scarce and conflicting (Forette, 1999).
Olive oil is the major source of fat in the Mediterranean
diet, and it has been firmly associated with improvements
in plasma lipid and lipoprotein levels and prevention of
cardiovascular disease (Mata et al. 1992; Perez-Jimenez
et al. 1995). In addition, it has been suggested recently
that dietary virgin olive oil (VOO) reduces blood pressure.
Ferrara et al. (2000) reported that VOO reduces the need
for medication in hypertensive subjects, and this effect
was attributed to enhanced NO levels by polyphenols. In
our laboratory, we demonstrated that in normotensive and
in hypertensive normocholesterolaemic and hypercholes-
terolaemic subjects dietary VOO lowered blood pressure
when compared with another oleic acid-rich oil, such as
high-oleic acid sunflower oil (HOSO) (Ruiz-Gutierrez
et al. 1996, 1997). Moreover, VOO, but not HOSO, also
normalized some altered functions of the erythrocyte mem-
brane in hypertensive subjects (Ruiz-Gutierrez et al. 1996).
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It was proposed that some other compounds distinct from
oleic acid might be responsible for such effects, since the
content of this fatty acid in VOO and HOSO was almost
identical. We have also observed that the differences in
the composition of triacylglycerol molecular species of
VOO and HOSO exerts influence on the triacylglycerol
composition of atherogenic triacylglycerol-rich lipopro-
teins, in both fasting (Ruiz-Gutierrez et al. 1998, 1999)
and postprandial (Abia et al. 1999, 2001) conditions.
Despite emerging results concerning the effects of VOO
on blood pressure and serum lipoprotein concentrations,
there is little information regarding elderly people, in
part because VOO has been frequently considered neutral
for cardiovascular disease (Busnach et al. 1998; Prisco
et al. 1998; Mori et al. 1999).
The present study was conducted with the aim of assessing
the effects of dietary VOO on blood pressure and on plasma
lipid and lipoprotein levels in a normocholesterolaemic and
normotensive elderly population (average age 85 years). In
order to evaluate the hypothetical influence of triacylglycerol
molecular species composition, we compared two VOO of
the same variety, with a similar composition of minor com-
ponents and fatty acids, except for oleic (18 : 1n-9) and lino-
leic (18 : 2n-6) acids. These slight differences in the fatty acid
composition were, however, reflected in the triacylglycerol
molecular species composition.
Materials and methods
Experimental design
A double-blind study was conducted over two 4-week
periods, during which each participant ate a diet enriched
in two VOO (Olea europaea var. hojiblanca; Grupo Hoji-
blanca, Antequera, Spain), VOO1 and VOO2, which sub-
stituted for sunflower oil- and maize oil-based margarines
consumed habitually (baseline). Subjects were assigned
to the VOO diets in a random-order sequence. A 4-week
washout period was included between the two periods,
during which the diet was returned to the baseline compo-
sition. Before the study, the health officers had recorded
the regular dietary intake of the participants for four con-
secutive weeks, using a 24 h recall and food-frequency
questionnaires. The energy consumption and nutrient
intake were calculated, approved by a dietitian and
employed as a basis for the diets of the study.
Subjects
The study was performed at Residencia Helio´polis (Junta
de Andalucı´a, Sevilla, Spain), a residential home for the
elderly, where the diet of all participants was controlled.
Twenty-two women and nine men, who were residents
at the beginning of the study, gave written, informed con-
sent to a protocol approved by the Institutional Committee
on Investigation in Humans (Hospitales Universitarios
Virgen del Rocı´o, Sevilla, Spain). The participants were
free-living and we gave them free food but no payment.
All participants had been residents of the Residencia
Helio´polis for at least 5 years, and consequently all
their habits were completely known. The average age of
the subjects was 84·9 (SD 6·4) years and their BMI was
28·0 (SD 4·8) kg/m2. All participants were normocholester-
olaemic and normotensive and none was diabetic or
suffered from glucose intolerance or hypothyroidism.
Fasting glucose levels were 94·4 (SD 8·4) mmol/l. None
of the subjects was receiving any antihypercholesterolae-
mic or antihypertensive treatment. Cigarette smokers
were excluded from the study and no case of alcohol
abuse was detected among participants.
Diets
The studied diets were based on ordinary food and were
planned for each 4-week period and were revised every
week. The only difference between the diets lay in the com-
position of edible fats added, in the form of oils (VOO1 and
VOO2) for cooking, salad dressing and occasionally for
spreading on slices of bread. The menus were the same
for each experimental period, including baseline, but the
daily diet was adjusted to 30 % energy as fat, 55 % as carbo-
hydrate and 15 % as protein, from nearly 35 % energy as fat
at baseline. The composition of the two oils was similar with
regard to minor components and fatty acids, except for the
oleic and linoleic acid content (Table 1). However, the
two oils presented substantial differences in the triacylgly-
cerol molecular species composition (Table 2). The analysis
of the fatty acid composition of the oils was performed by
GC as described later for fatty acid determination of
Table 1. Fatty acid (g/100 g total fatty acids) and minor com-
ponents (g/kg) of the two virgin olive oils employed in the exper-
imental diets (VOO1 and VOO2)
(Mean values and standard deviations)
VOO1 VOO2
Mean SD Mean SD
Fatty acids
16 : 0 10·9 1·8 13·9 1·9
16 : 1n-7 1·1 0·3 1·3 0·2
18 : 0 2·4 1·3 1·8 1·0
18 : 1n-9t 0·3 0·2 0·3 0·2
18 : 1n-9 74·6 0·6 66·5** 2·0
18 : 1n-7 3·5 0·1 4·6 0·6
18 : 2n-6 4·5 0·4 9·7** 1·4
18 : 3n-3 0·6 0·2 0·5 0·1
18 : 3n-6 1·1 0·3 0·9 0·1
20 : 1n-9 0·2 0·1 0·1 0·0
22 : 0 0·8 0·1 0·1 0·1
SFA 13·9 2·0 15·9 0·9
MUFA 79·3 0·3 72·4** 1·7
PUFA 6·2 0·6 11·1 1·5
Unsaponifiable matter (mg/g) 1·2 0·2 1·2 0·3
Sterols (mg/100 g)
Campesterol 3·3 0·0 3·7 0·1
Stigmasterol 1·1 0·2 0·7 0·1
Clerosterol 1·4 0·7 1·1 0·3
b-Sitosterol 85·4 2·7 86·4 1·8
D-5-avenasterol 7·3 1·0 7·3 1·6
Others 1·5 0·9 1·0 0·4
Polyphenols (mg/g) 202·1 18·6 233·0 15·9
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyun-
saturated fatty acid.
Mean values were significantly different from those of VOO1: ** P,0·01.
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plasma phospholipids and cholesteryl esters. With regard to
the non-fatty acid constituents, we fully determined total
sterols, after extraction of the unsaponifiable matter and
polyphenols as described previously (Ruiz-Gutierrez et al.
1997, 2000). Triacylglycerol composition was determined
by reversed-phase HPLC following the method described
by Perona & Ruiz-Gutierrez (1999).
Three diet samples were collected in each experimental
period to be analysed for their fat content and other nutri-
ents. One investigator was present several times in the
kitchen during meal preparation without previous notifica-
tion. The energy consumption was approximately 7530 kJ
(1800 kcal)/d and the cholesterol intake was approximately
307 mg/d. Na and Ca intakes were identical in the baseline
period and in both experimental periods.
Blood pressure measurements
Blood pressure measurements were performed in the morn-
ing after an overnight fast, at the right brachial artery in
seated participants using a Hg-gauge sphygmomanometer.
At each visit three blood pressure measurements were
used to determine eligibility. In addition, blood pressure
was recorded at the beginning, middle and end of each
experimental period. The measurement at the beginning
of the first experimental period was considered as baseline
and it was corroborated by a measurement at the washout
period. All these measurements were performed under
the same conditions.
Plasma lipid and lipoprotein analyses
Venous blood was obtained after an overnight fast, at the
beginning and end of each period of the study. Blood
was collected in Vacutainerw tubes (Beckton Dickinson,
Meylan Cedex, France) and plasma obtained by centrifu-
gation at 1500 rpm for 30 min at 48C. Plasma samples
were frozen below 2808C until analysed. Plasma total
cholesterol and triacylglycerol concentrations and
cholesterol concentrations in LDL and HDL were
measured by conventional enzymatic methods (Bucolo &
David, 1973; Allain et al. 1974).
Determination of plasma phospholipid and cholesteryl
ester fatty acid composition
Total lipids were extracted following a modification of the
method of Rose & Oaklander (1965), using 2,6-di-tert-
butyl-p-cresol as antioxidant. Lipids were separated into
fractions by TLC on silica gel 60 plates (Kieselgel 60
F254; Merck Espana, Barcelona, Spain) using an elution
system of n-hexane–diethyl ether–acetic acid (80:20:1,
by vol.) (Merck), according to the method of Ruiz-
Gutierrez et al. (1992). The phospholipid and cholesteryl
ester fractions were scrapped off the silica, eluted with
chloroform–methanol (1:1, v/v) and n-hexane respectively,
passed through a N2 stream and stored at temperature
below 2208C until analysed, always within the following
few days.
Phospholipids and cholesteryl esters were transmethy-
lated and the resulting fatty acid methyl esters analysed
by GC as described by Ruiz-Gutie´rrez et al. (1992) using
a model 5890 series II GC (Hewlett-Packard Co., Avon-
dale, PA, USA) equipped with a flame ionization detector
and a capillary silica column Supelcowax 10 (Sulpelco
Co., Bellefonte, CA, USA) of 60 m length and 0·25 mm
internal diameter. Individual fatty acid methyl esters
were identified by means of comparison of the retention
times with those of standards. Fatty acid methyl esters
for which no standards were available were identified by
GC–MS on a Konik KNK-2000 chromatograph (Konik
Co., Barcelona, Spain) interfaced directly to an AEJ
MS30/790 VG MS (VG Analytical, Manchester, UK)
using electron impact ionization mode. The ion source tem-
perature was maintained at 2008C, the multiplier voltage
was 4·0 kV, the emission current was 100mA and the elec-
tron energy was 70 eV. The data were processed with a VG
11/250 data system (VG Analytical).
Statistical analyses
Values are shown as means and standard deviations. Data
were evaluated by ANOVA with Tukey’s post hoc com-
parison of the mean values and Pearson test for corre-
lations. The significance of the differences between diets
was evaluated by using a two-tailed unpaired t test. Differ-
ences were considered significant with a 99 % CI
(P,0·01). The analyses were done with the SPSS package
(v. 11.0.1; SPSS Inc. Chicago, IL, USA).
Results
All participants completed the study according to schedule.
The assistant personnel for the study estimated compliance
with the diets to be close to 90 % from the evaluation of
daily food questionnaires and the visual examination of
Table 2. Triacylglycerol molecular species compo-
sition (mg/g) of the two virgin olive oils employed in
the experimental diets (VOO1 and VOO2)
(Mean values and standard deviations)
VOO1 VOO2
Triacylglycerol Mean SD Mean SD
LLL ND ND ND ND
OLL ND ND 21 2
PLL 17 3 15** 3
OOL 70 3 152** 13
POL 34 1 69** 13
OOO 429 24 304** 30
SOL ND ND 17 0
POO 277 6 263 14
PPO þ PLS 42 3 44 8
PPP 14 1 14 0
SOO 58 1 48 11
POS 24 4 19 4
SSO 20 4 6 1
SSP 16 1 ND ND
ND, not detected; LLL, trilinoleoyl–glycerol; O, oleic acid;
L, linoleic acid; P, palmitic acid; S, stearic acid; POO, pal-
mitoyl–dioleoyl–glycerol; POS, palmitoyl–oleoyl–stear-
oyl–glycerol.
Mean values were significantly different from those of
VOO1: **P,0·01.
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the food remaining on the plates after every meal. Body
weight was maintained after both VOO periods (baseline
67·3 (SD 11·5) (P=0·324), after VOO1 71·1 (SD 13·7)
(P=0·956), after VOO2 67·0 (SD 12·7) (P=0·348) kg).
Both VOO1 and VOO2 diets were responsible for a
similar reduction in systolic pressure, accounting for 10
and 12 mmHg respectively (P,0·01). Baseline systolic
pressure was 143 (SD 8) mmHg, whereas this value after
VOO1 was 133 (SD 7) mmHg and after VOO2 131 (SD
7) mmHg. Diastolic pressure was not significantly modified
after consuming both VOO, and was maintained at average
levels of about 70 mmHg.
The intake of VOO1, but not VOO2, was responsible for
a reduction of plasma total cholesterol (by 10 %, P,0·01)
and LDL-cholesterol (by 12 %, P,0·01) levels of elderly
people compared with baseline (Table 3). Conversely, an
increment in the serum triacylglycerol (by 24 % after
VOO1, P,0·01 and by 31 % after VOO2, P,0·01) and
a decrease in HDL-cholesterol (by 8 % after VOO1,
P,0·01 and by 7 % after VOO2, P,0·01) concentrations
were found after both periods. This slight, though signifi-
cant, decrease in HDL-cholesterol concentration prevented
a reduction in the total cholesterol:HDL-cholesterol and
LDL-cholesterol:HDL-cholesterol ratios.
The plasma cholesteryl ester fatty acid composition is
shown in Table 4. The consumption of VOO (VOO1 and
VOO2) elevated the oleic acid content in these molecules
by about 30 % (P,0·01). Although mirystoleic (14 : 1n-5)
and palmitoleic acids (16 : 1n-7) were only increased
after VOO1 (P,0·01), the elevation in the oleic acid con-
tent resulted in a significant increase in total monounsatu-
rated fatty acids after both dietary periods (by 28 % after
VOO1 and by 20 % after VOO2, P,0·01). However, lino-
leic acid and total polyunsaturated fatty acids were lowered
in the plasma cholesteryl ester fraction after VOO1 (by 11
and 10 % respectively, P,0·01), but not after VOO2. Cor-
respondingly, the linoleic acid:oleic acid ratio was reduced
after both experimental periods, but to a greater extent after
VOO1 (about 31 % after VOO1 and about 22 % after
VOO2, P,0·01). In addition, the consumption of VOO2
lowered the content of total saturated fatty acids by 18 %
(P,0·01) compared with baseline and VOO1.
Modifications in the plasma phospholipid fatty acid
composition of the elderly subjects by the experimental
diets were less evident (Table 5). For instance, the introduc-
tion of VOO in diet did not increase the incorporation of
oleic acid to phospholipids. Indeed, the concentration of
this fatty acid was significantly lower in plasma phospholi-
pids after VOO2 compared with VOO1 and baseline diets
(by 17 and 12 % respectively, P,0·01). As a consequence,
the total monounsaturated fatty acid content was also lower
after VOO2 (by 18 % after baseline and VOO1, P,0·01).
Linoleic acid was less efficiently incorporated to phospho-
lipids in subjects consuming VOO1 (P,0·01), but a signifi-
cant difference in the linoleic acid:oleic acid ratio could not
be detected. Arachidonic acid (20 : 4n-6) was slightly
increased in plasma phospholipids after both VOO diets
(VOO1 and VOO2) being significant only after VOO1
(P,0·01). Both VOO diets also induced the incorporation
of polyunsaturated fatty acids (n-3) into phospholipids.
At baseline, n-3 fatty acids could not be found, but
after VOO1 and VOO2, a-linolenic (18 : 3n-3), eicosapen-
taenoic (20 : 5n-3), docosapentaenoic (22 : 5n-3) and
docosahexaenoic (22 : 6n-3) acids appeared.
Plasma cholesteryl ester and phospholipid oleic and
linoleic acids were plotted against plasma total and
LDL-cholesterol concentrations (Table 6). Both fatty
acids showed statistically significant linear correlations
(r 2.0·469, P,0·01), which were inverse in the dietary
periods studied (VOO1 and VOO2), except when oleic
acid concentration in plasma phospholipids after
VOO1 was plotted against LDL-cholesterol (P=0·120).
The strongest correlation was found relating oleic acid in
phospholipids with LDL-cholesterol after VOO2
(r 2 0·720, P=0·001).
Table 3. Plasma lipid levels (mg/l) of elderly subjects at baseline
and after consuming the two virgin olive oil diets (VOO1 and
VOO2)*
(Mean values and standard deviations for thirty-one elderly
subjects)
Baseline VOO1 VOO2
Mean SD Mean SD Mean SD
chol 1862a 381 1666b 377 1884a 431
LDL-chol 1130a 355 992b 324 1236a 379
HDL-chol 576a 178 481b 149 435b 147
Total chol:HDL-chol 33 10 36 10 43 12
LDL-chol:HDL-chol 20 9 22 8 26 12
Triacylglycerol 776a 300 963b 431 1023b 579
chol, cholesterol.
a,bMean values within a row with unlike superscript letters were significantly
different (P,0·01).
* For details of diets and procedures, see Tables 1 and 2 and p. 820.
Table 4. Plasma cholesteryl ester fatty acid composition (g/100 g
total fatty acids) of elderly subjects at baseline and after consuming
the two virgin olive oil diets (VOO1 and VOO2)*
(Mean values and standard deviations for thirty-one elderly subjects)
Baseline VOO1 VOO2
Fatty acid Mean SD Mean SD Mean SD
14 : 0 0·4a 0·3 0·5a 0·2 0·2c 0·2
14 : 1n-5 0·5a 0·2 1·6b 0·1 0·3a 0·1
16 : 0 14·0a 2·9 13·3ab 3·1 11·8b 2·1
16 : 1n-9 2·1a 0·8 1·9ab 1·0 1·3b 0·7
16 : 1n-7 2·0a 0·5 3·2b 0·9 2·2ac 0·6
18 : 0 2·1a 0·7 2·2a 1·1 1·3b 0·6
18 : 1n-9 15·9a 3·1 20·2b 3·4 21·3b 2·7
18 : 1n-7 1·8 0·4 1·7 0·4 1·7 0·3
18 : 2n-6 49·9a 4·6 44·4b 6·8 49·1a 3·9
18 : 3n-6 1·2 0·3 1·2 0·5 1·0 0·4
18 : 3n-3 0·3 0·1 0·3 0·1 0·3 0·1
20 : 0 ND ND 0·1 0·0 0·1 0·0
20 : 2n-6 1·0 0·3 1·0 0·2 1·0 0·3
20 : 4n-6 8·8 1·3 8·4 1·8 8·3 1·5
SFA 16·5a 4·0 16·1a 4·5 13·4b 2·9
MUFA 22·3a 5·1 28·6b 5·8 26·8b 4·5
PUFA 61·2a 6·6 55·3b 9·4 59·7a 6·2
18 : 2/18 : 1 3·2a 0·7 2·2b 0·4 2·5c 0·5
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyun-
saturated fatty acid; ND, not detected.
a,b,cMean values within a row with unlike superscript letters were significantly
different (P,0·01).
* For details of diets and procedures, see Tables 1 and 2 and p. 820.
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Discussion
In the present study we compared the effects of two diets
rich in VOO (VOO1 and VOO2), with an equivalent com-
position of minor components but differing in their content
of oleic and linoleic acids, and thus, in the triacylglycerol
molecular species composition, on plasma lipids and blood
pressure of healthy elderly people. Our present results have
demonstrated for the first time that dietary VOO lowers
systolic blood pressure among very old people (average
85 years). Unfortunately, for the moment there are few
results available on the effects of dietary oils on blood
pressure in such a population group. Two double-blind ran-
domized-controlled studies have compared the effects on
blood pressure of the administration of n-3 (fish oil) and
n-6 fatty acids, in the form of capsules, to elderly people,
and have reported a greater reduction of blood pressure
in hypertensive patients receiving fish oil (Varicel et al.
1999; Wensing et al. 1999). When the intake of capsules
of fish oil was compared with olive oil as a placebo, no
significant effect in the reduction of blood pressure was
found (Meland et al. 1989; Wing et al. 1990; Du Plooy
et al. 1992).
Ruiz-Gutierrez et al. (1996, 1997) demonstrated that
VOO reduces blood pressures of healthy and hypertensive
subjects compared with HOSO, and suggested that the
lack of effect found after the intake of HOSO was due to
differences in non-fatty acid constituents, such as triacylgly-
cerol molecular species or minor components. In the present
study we have found no significant differences in the effect
of VOO1 and VOO2 in regard to blood pressure. The anal-
ysis of the oils employed in the diets revealed differences in
the triacylglycerol molecular species composition between
them but a virtually identical composition of the minor com-
ponent fraction. Therefore, our present results support the
idea that minor components might be related to the
reduction of blood pressure, at least in elderly people.
Table 5. Plasma phospholipid fatty acid composition (g/100 g total
fatty acids) of elderly subjects at baseline and after consuming the
two virgin olive oil diets (VOO1 and VOO2)*
(Mean values and standard deviations for thirty-one elderly subjects)
Baseline VOO1 VOO2
Fatty acid Mean SD Mean SD Mean SD
14 : 0 0·5 0·2 0·5 0·2 0·4 0·2
14 : 1n-5 0·6 0·2 0·7 0·3 0·7 0·2
16 : 0 28·6 2·5 27·9 2·5 29·2 2·7
16 : 1n-9 0·5a 0·2 0·5a 0·3 0·2b 0·1
16 : 1n-7 0·7a 0·3 1·0a 0·4 0·6b 0·2
16 : 4n-7 0·6a 0·2 0·4b 0·2 0·4b 0·1
18 : 0 15·0 2·7 14·6 3·0 14·8 1·4
18 : 1n-9t 1·0 0·1 0·5 0·3 0·1 0·0
18 : 1n-9 14·0a 2·6 13·2a 2·9 11·6b 1·5
18 : 1n-7 2·0 0·6 2·0 0·6 2·0 0·6
18 : 2n-6 20·1a 2·4 18·5b 2·0 20·0c 3·1
18 : 3n-6 0·4a 0·1 0·3a 0·2 0·2b 0·1
18 : 3n-3 ND ND 0·2 0·0 0·2 0·1
20 : 0 0·2a 0·1 0·2a 0·1 0·1b 0·0
20 : 1n-9 0·3a 0·1 0·6b 0·4 0·2c 0·0
20 : 1n-7 0·2a 0·0 0·1b 0·1 0·1a 0·1
20 : 2n-6 3·3a 0·6 3·6a 1·0 3·8b 0·4
20 : 4n-6 10·3a 2·3 11·9b 2·3 11·4a 2·4
22 : 0 ND ND ND ND 0·5 0·0
20 : 5n-3 ND ND 0·1 0·0 0·4 0·0
22 : 1n-9 0·6a 0·1 1·0a 0·8 0·1b 0·0
22 : 4n-6 0·5 0·1 0·5 0·2 0·5 0·2
22 : 5n-6 0·3 0·1 0·3 0·0 0·4 0·1
22 : 5n-3 ND ND 0·8a 0·5 0·4b 0·1
22 : 6n-3 ND ND 0·3 0·1 0·4 0·1
24 : 1n-9 ND ND ND ND 0·5 0·1
SFA 44·4 5·6 43·2 5·8 45·1 4·4
MUFA 19·8a 4·3 19·6a 5·6 16·2b 3·0
PUFA 35·9 6·0 37·3 7·1 37·6 7·2
18 : 2/18 : 1 1·5 0·3 1·4 0·3 1·8 0·4
SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyun-
saturated fatty acid; ND, not detected.
a,b,cMean values within a row with unlike superscript letters were significantly
different (P,0·01).
* For details of diets and procedures, see Tables 1 and 2 and p. 820.
Table 6. Correlations between cholesteryl ester (CE) and phospholipid (PL) oleic (O) and linoleic (L) acids
concentrations with variations in plasma total (T) and LDL-cholesterol (chol) concentrations from baseline, after
consuming the two virgin olive oil diets (VOO1 and VOO2)*
Variables r 2 P Equation SE† SE‡ SE§ n
CE
VOO1 O–Tchol 0·523 0·015 y=25·743x+101·100 18·9 1·5 28·6 26
L–Tchol 0·485 0·039 y=2·199x2102·812 18·5 2·6 18·3 26
O–LDL-chol 0·511 0·018 y=26·461x+119·863 21·8 1·7 32·9 26
L–LDL-chol 0·574 0·010 y=2·919x2137·739 20·6 0·7 31·4 26
VOO2 O–Tchol 0·544 0·040 y=23·919x+89·352 18·7 1·1 23·8 22
L–Tchol 0·485 0·027 y=1·722x278·379 14·2 0·5 22·6 22
O–LDL-chol 0·609 0·006 y=24·969x+113·804 19·2 1·1 24·3 22
L–LDL-chol 0·666 0·002 y=4·447x2212·689 26·0 0·9 41·4 22
PL
VOO1 O–Tchol 0·598 0·032 y=27·088x+86·451 15·3 1·8 27·8 26
L–Tchol 0·469 0·010 y=6·241x2109·708 18·1 2·0 38·0 26
O–LDL-chol 0·225 0·120 y=25·286x+60·554 26·1 3·1 47·2 26
L–LDL-chol 0·548 0·038 y=7·585x2150·673 18·8 2·1 39·4 26
VOO2 O–Tchol 0·696 0·000 y=26·680x+84·794 11·1 1·2 15·3 22
L–Tchol 0·688 0·002 y=5·847x2124·128 12·7 1·2 27·1 22
O–LDL-chol 0·720 0·001 y=29·150x+120·385 13·1 1·4 17·7 22
L–LDL-chol 0·492 0·016 y=9·350x2190·823 25·7 2·4 52·9 22
* For details of diets and procedures, see Tables 1 and 2 and p. 820.
† Standard error of the correlation.
‡ Standard error of the slope.
§ Standard error of the independent term.
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Interestingly, our present results have revealed that total
cholesterol and LDL-cholesterol concentrations were
reduced after the period of consuming VOO1, but not
after VOO2, compared with baseline diet, which was
rich in sunflower oil- and maize oil-based margarine
(Table 3). Numerous studies have suggested that dietary
intake of olive and sunflower oils has similar effects
on plasma lipid concentrations (Gustafsson et al. 1992;
Mata et al. 1992; Trautwein et al. 1999). However,
there is still need for consensus on this effect. Some
recent studies designed to compare the effects of olive
oil with other n-6 fatty acid-rich oils on human plasma
lipid concentrations have shown increasing cholesterol
and LDL-cholesterol levels after consuming olive oil
(Howell et al. 1998; Pedersen et al. 2000). In contrast,
others have reported cholesterol reductions by olive oil
(Sirtori et al. 1992; Madigan et al. 2000). These discre-
pancies may be due to differences in experimental con-
ditions, including the employment of different varieties
of olive oil. Since the dietary VOO employed in the pre-
sent study were of the same variety (hojiblanca) and had a
similar content of minor components, the difference
observed in the reduction of total cholesterol and LDL-
cholesterol levels in elderly people cannot be attributed
to this fraction. The adjustment of dietary fat content
might result in the concomitant reduction in HDL-choles-
terol levels observed, according to Morgan et al. (1993).
Several authors have reported results showing that not
all monounsaturated oils have the same effect on plasma
cholesterol (Perez-Jimenez et al. 1995; Ruiz-Gutierrez
et al. 1996; Truswell & Choudhury, 1998). Studies
comparing the effects of VOO and HOSO revealed that
the former improved plasma lipid metabolism and erythro-
cyte membrane homeostasis (Ruiz-Gutierrez et al. 1996,
1997; Abia et al. 1999, 2001). These oils have a similar
fatty acid composition, but differ in their triacylglycerol
molecular species content. For this reason, those studies
suggested that triacylglycerols were not merely fatty
acid transporters and might have a relevant role in such
effects. The oils employed in the present study were
selected to present differences in this lipid class: whereas
VOO1 contained a greater amount of triolein, VOO2 was
significantly enriched in species containing linoleic acid
(Table 2). We have previously demonstrated that lino-
leoyl-species of triacylglycerols from HOSO were incor-
porated to a greater extent into chylomicrons and VLDL
compared with VOO (Ruiz-Gutierrez et al. 1999; Abia
et al. 1999, 2001).
The present results show that in addition to triacylgly-
cerols, dietary linoleic acid is also relatively conserved
in plasma as phospholipids and cholesteryl esters. The
plasma cholesteryl ester fatty acid composition of the
elderly subjects confirmed the addition of VOO to
the diet. Cholesteryl oleate was increased in plasma by
about 30 % compared with baseline after both periods
of consuming VOO. However, a concomitant reduction
in the content of cholesteryl linoleate was observed
only after the VOO1 period. Indeed, the concentration
of linoleic acid was also lower in plasma phospholipids
after VOO1. Interestingly, this was the only period in
which total cholesterol and LDL-cholesterol was reduced
from baseline. Thus, we investigated for a link between
oleic and linoleic acids in cholesteryl esters and phospho-
lipids with plasma total cholesterol and LDL-cholesterol.
Both fatty acids showed a statistically significant linear
correlation with these plasma variables, being inverse
in the experimental periods studied (VOO1 and VOO2).
Thus, the greater concentration of oleic acid in choles-
teryl esters and phospholipids, the lower the levels of
plasma total cholesterol and LDL-cholesterol. In plasma,
the transfer of cholesteryl esters and phospholipids from
HDL towards apolipoprotein B-containing lipoproteins
(LDL and VLDL) are mediated by the cholesteryl ester
transfer protein and phospholipid transfer protein
respectively, which can be regulated by dietary fatty
acids (Lagrost et al. 1999). In particular, oleic acid
reduces plasma cholesteryl ester transfer protein activity
compared with dietary linoleic (Kurushima et al. 1995),
palmitic (Lagrost et al. 1999) and elaidic (Abbey &
Nestel, 1994) acids. In human subjects, cholesteryl ester
transfer protein activity and concentration have been
proposed as determinants of plasma LDL-cholesterol
levels since these variables correlate positively (Kinoshita
et al. 1996; Moulin, 1996). Accordingly, the decreased
levels of LDL-cholesterol found in plasma of elderly
people in the present study after VOO1 might be related
to the higher concentration of plasma oleic acid in
phospholipids and cholesteryl esters and/or to the dimin-
ishing concentrations of linoleic acid in these molecules.
In conclusion, we observed that both dietary oils studied
(VOO1 and VOO2) exhibited the same effect on blood
pressure and as an equivalent composition of minor com-
ponents was found in them, we suggest that this fraction
might be responsible for the reduction of blood pressure
documented here and in other studies. However, we
found that, compared with VOO2, VOO1 reduced plasma
total cholesterol and LDL-cholesterol in elderly people
and that this reduction was related to the incorporation of
oleic acid into plasma phospholipids and cholesteryl
esters. This incorporation was related to differences in
the triacylglycerol molecular species compositions of the
oils, since VOO1 was enriched in triolein, whereas
VOO2 was enriched in triacylglycerols containing linoleic
acid. Therefore, the present results stress the importance of
the dietary oil choice, since not all VOO have the same
effects on risk factors related to cardiovascular disease.
We suggest that the VOO variety and its content of
minor components and triacylglycerol molecular species
must be considered in that choice.
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